Authors’ Reply to Juergen O Kirchner’s Comment on “Incidence Rates of Autoimmune Diseases in European Healthcare Databases: A Contribution of the ADVANCE Project”-Reference-Cited by-同舟云学术

Authors’ Reply to Juergen O Kirchner’s Comment on “Incidence Rates of Autoimmune Diseases in European Healthcare Databases: A Contribution of the ADVANCE Project”

Published:2023-05-27 Issue:8 Volume:46 Page:813-815
ISSN:0114-5916
Container-title:Drug Safety
language:en
Short-container-title:Drug Saf

Author:

Willame Corinne^ORCID,Weibel Daniel,Sturkenboom Miriam C. J. M.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Toxicology

Link

https://link.springer.com/content/pdf/10.1007/s40264-023-01311-6.pdf

Reference12 articles.

1. Kirchner J. Comment on “Rates of autoimmune diseases in European healthcare databases: a contribution of the ADVANCE project”. Drug Saf. 2023. https://doi.org/10.1007/s40264-023-01310-7

2. Sturkenboom M, Bahri P, Chiucchiuini A, Grove KT, Hahné S, Khromava A, Kokki M, Kramarz P, Kurz X, Larson HJ, de Lusignan S, Mahy P, Torcel-Pagnon L, Titievsky L, Bauchau V, ADVANCE consortium. Why we need more collaboration in Europe to enhance post-marketing surveillance of vaccines. Vaccine. 2020;38(Suppl 2):B1–7. https://doi.org/10.1016/j.vaccine.2019.07.081. (Epub 2019 Oct 31. PMID: 31677952).

3. Willame C, Dodd C, Durán CE, Elbers R, Gini R, Bartolini C, Paoletti O, Wang L, Ehrenstein V, Kahlert J, Haug U, Schink T, Diez-Domingo J, Mira-Iglesias A, Carreras JJ, Vergara-Hernández C, Giaquinto C, Barbieri E, Stona L, Huerta C, Martín-Pérez M, García-Poza P, de Burgos A, Martínez-González M, Bryant V, Villalobos F, Pallejà-Millán M, Aragón M, Carreras JJ, Souverein P, Thurin NH, Weibel D, Klungel OH, Sturkenboom M. Background rates of 41 adverse events of special interest for COVID-19 vaccines in 10 European healthcare databases—an ACCESS cohort study. Vaccine. 2023;41(1):251–62. https://doi.org/10.1016/j.vaccine.2022.11.031. (Epub 2022 Nov22. PMID: 36446653; PMCID: PMC9678835).

4. Willame C, Dodd C, van der Aa L, Picelli G, Emborg HD, Kahlert J, Gini R, Huerta C, Martín-Merino E, McGee C, de Lusignan S, Roberto G, Villa M, Weibel D, Titievsky L, Sturkenboom MCJM. Incidence rates of autoimmune diseases in European Healthcare Databases: a contribution of the ADVANCE Project. Drug Saf. 2021;44(3):383–95. https://doi.org/10.1007/s40264-020-01031-1. (Epub 2021 Jan 19. PMID: 33462778; PMCID:PMC7892524).

5. Dubey D, Pittock SJ, Kelly CR, et al. Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis. Ann Neurol. 2018;83(1):166–77. https://doi.org/10.1002/ana.25131.